In theory yes, but one can be infected with a virus with CXCR4 tropism or at least with mixed/dual populations of HIV. That will limit CCR5 inhibitors utility.

Much more attractive is the use of integrase inhibitors instead.

In fact, the point is that infection through sexual contact takes the DC cells pathway, with no need for coreceptors to enter LT CD4